There it is!! AZD-103 to get 2nd /3rd Phase2
.
AZD-103 is going to get other Clinical Trials started in other Indications......THATS HUGE.
It's in this Quarters MD & A ......just like Elan CEO Kelly Martin Said...." AZD-103/ELND005 WILL be getting another Phasell started This Year in Early Alzheimers ....likely in H2/2008"
From Q2/08 MD&A....."Transition and its partner Elan are considering initiating clinical trials for OTHER Amyloid-Beta Related Indications including Pre-Alzheimer’s disease."
Can you say MCI??......25 million people in the US with it......HUGE!!